All Stories

  1. Ethnicity affects IVF outcome world-wide with no clear explanation
  2. Phase IV, open-label, randomized study of low-dose recombinant human follicle-stimulating hormone protocols for ovulation induction
  3. Is it useful to continue administration of gonadotropin releasing hormone (GnRH) agonist after embryo transfer?
  4. The effectiveness of reducing the incidence of preterm birth in IVF/ICSI twins using natural progesterone starting from the first trimester
  5. Impact of antimüllerian hormone assays on the outcomes of in vitro fertilization: a prospective controlled study
  6. Secured Lossless Medical Image Compression Based On Adaptive Binary Optimization
  7. A Survey and Study of Image Compression Methods
  8. BOOK REVIEW
  9. Insulin resistance: a new diagnosis for the pathogenesis of idiopathic oligozoospermia and non-obstructive azoospermia
  10. BOOK REVIEW
  11. GnRH antagonist administration for patients at high risk of severe Ovarian Hyperstimulation Syndrome (OHSS) down regulated GnRH agonist
  12. Prospective randomised study comparing luteal phase support in in-vitro fertilisation/intracytoplasmic sperm injection patients for three weeks versus seven weeks from day of positive pregnancy test
  13. Purified urinary follicle stimulating hormone (FSH) and recombinant FSH follitropin-alpha for polycystic ovarian syndrome (PCOS) patients undergoing intra-cytoplasmic sperm injection (ICSI)
  14. The possible role of natural cycle and modified natural cycle in IVF
  15. BOOK REVIEW
  16. BOOK REVIEW
  17. Reply of the Authors
  18. ICSI or IVF in Nonmale-Factor Infertility?
  19. BOOK REVIEW
  20. Agonist and antagonist coast
  21. Would Gestational Age and Presence of Brain Anomalies Affect Interobserver Reliability of Fetal Head Biometry? Using Off-Line Analysis of 3-D Dataset
  22. Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro fertilization/intracytoplasmic sperm injection: a prospective randomized study
  23. BOOK REVIEW
  24. Barriers to conducting clinical research in reproductive medicine: Egypt
  25. Ovarian Stimulation edited by Mohamed Aboulghar, Botros Rizk
  26. Bob Edwards and Egypt
  27. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
  28. 1 Ovarian hyperstimulation syndrome and ultrasound
  29. Intra-venous fluids for the prevention of severe ovarian hyperstimulation syndrome
  30. Effects of Multicollinearity on the Estimation of Macroeconomic Variables by Using Data from Sudan
  31. Ovarian Stimulation
  32. Ovarian hyperstimulation syndrome
  33. Procedures before, during, and after ovarian stimulation
  34. Non-conventional forms used during ovarian stimulation
  35. How to select ovarian stimulation protocols to avoid difficulties and complications
  36. Treatment of hyperprolactinemia
  37. Treatment of Ovarian Hyperstimulation Syndrome
  38. The impact of vanishing fetuses on the outcome of ICSI pregnancies
  39. Does the outcome of ICSI in cases of obstructive azoospermia depend on the origin of the retrieved spermatozoa or the cause of obstruction? A comparative analysis
  40. Coasting: What is the Cost?
  41. BIOGRAPHY OF CONTRIBUTORS
  42. Is there a consensus view on polycystic ovarian syndrome?
  43. Editorial
  44. Luteal support in reproduction: when, what and how?
  45. Prevention of OHSS
  46. Ultrasound cervical measurement and prediction of spontaneous preterm birth in ICSI pregnancies: a prospective controlled study
  47. Electrical activation of oocytes after intracytoplasmic sperm injection: a controlled randomized study
  48. Highly purified hMG achieves better pregnancy rates in IVF cycles but not ICSI cycles compared with recombinant FSH: a meta-analysis
  49. The patient with poor sperm quality
  50. The couple with unexplained infertility
  51. OC163: Transvaginal ultrasound guided needle aspiration in the management of patients with simple ovarian cysts
  52. OP15.09: Epidemiological characteristics of ultrasonographically detected congenital anomalies in Egyptian women
  53. Hydrosalpinx and the outcome of IVF: current status
  54. Prospective randomized study comparing luteal phase support for ICSI patients up to the first ultrasound compared with an additional three weeks
  55. Efficacy and safety of human menopausal gonadotrophins versus recombinant FSH: a meta-analysis
  56. Efficacy and safety of commercially available highly purified FSH vs. recombinant follicle stimulating hormone: a meta-analysis
  57. Efficacy and safety of highly purified hMG vs. recombinant follicle stimulating hormone: a meta-analysis
  58. Preventing Ovarian Hyperstimulation Syndrome
  59. A prospective randomized study comparing coasting with GnRH antagonist administration in patients at risk for severe OHSS
  60. Ethical aspects and regulation of assisted reproduction in the Arabic-speaking world
  61. P-72
  62. Gonadotrophin-releasing hormone antagonists for assisted conception
  63. In vitro fertilisation versus tubal reanastomosis (sterilisation reversal) for subfertility after tubal sterilisation
  64. HMG versus rFSH for ovulation induction in developing countries: a cost–effectiveness analysis based on the results of a recent meta-analysis
  65. Ultrasound-guided Versus Clinical Touch Embryo Transfer: A Systematic Reviews & Meta-analysis
  66. Classification, pathophysiology and management of ovarian hyperstimulation syndrome
  67. COMMENTARY: The importance of fertility treatment in the developing world
  68. Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles
  69. Ovulation induction in the new millennium: Recombinant follicle-stimulating hormone versus human menopausal gonadotropin
  70. Use of GnRHa to induce ovulation in GnRH antagonist cycles
  71. Optimizing GnRH antagonist administration: meta-analysis of fixed versus flexible protocol
  72. Current status of management of endometriomas
  73. OC091: 3D endometrial volume on day of hCG and IVF outcome: a prospective study
  74. Increasing the dose of human menopausal gonadotrophins on day of GnRH antagonist administration: randomized controlled trial
  75. Percutaneous aspiration biopsy using an intravenous catheter for testicular sperm retrieval in patients with obstructive azoospermia
  76. Chromosomal abnormalities of 1,022 couples entering ICSI program
  77. Increasing the dose of human menopausal gonadotrophins on day of GnRH antagonists administration: a randomized controlled trial
  78. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures
  79. Pregnancy rate is not improved by delaying embryo transfer from days 2 to 3
  80. The outcome of in vitro fertilization in advanced endometriosis with previous surgery: A case-controlled study
  81. Standard IVF and ICSI—how much do the conclusions differ?
  82. Recombinant versus urinary human chorionic gonadotrophin for ovulation induction in assisted conception
  83. Inter-digitation approach to encapsulation of C60: [C60 ⊂ (p-phenylcalix[5]arene)2]Dedicated to Professor Jerry L. Atwood on the occasion of his 60th birthday.
  84. Intra-venous fluids preventing severe ovarian hyperstimulation syndrome
  85. Spontaneous intrauterine pregnancy following salpingectomy for a unilateral hydrosalpinx: Case report
  86. Gonadotrophin-releasing hormone antagonists for assisted conception
  87. A prospective controlled study of karyotyping for 430 consecutive ICSI babies.
  88. A prospective controlled study of karyotyping for 430 consecutive babies conceived through intracytoplasmic sperm injection
  89. Controlled ovarian hyperstimulation and intrauterine insemination for treatment of unexplained infertility should be limited to a maximum of three trials
  90. Single Large Testicular Biopsy is Comparable to Multiple Biopsies to Retrieve Spermatozoa in Patients with Non-Obstructive Azoospermia
  91. Regulation of fertility treatment and research
  92. Management of long-standing unexplained infertility: A prospective study
  93. Multifetal pregnancy reduction: modification of the technique and analysis of the outcome
  94. Intracytoplasmic Sperm Injection in Difficult Cases: The Egyptian Experience
  95. Controversies in the modern management of hydrosalpinx
  96. Complications of medically assisted conception in 3,500 cycles
  97. Notes and News
  98. Fertilization and pregnancy rates after intracytoplasmic sperm injection using ejaculate semen and surgically retrieved sperm
  99. Reply of the Authors
  100. Intracytoplasmic sperm injection and conventional in vitro fertilization for sibling oocytes in cases of unexplained infertility and borderline semen
  101. In vitro Fertilization in a Spontaneous Cycle: A Successful Simple Protocol
  102. Ultrasonographically guided transvaginal aspiration of tuboovarian abscesses and pyosalpinges: An optional treatment for acute pelvic inflammatory disease
  103. In vivo survival of spermatozoa in the human fallopian tube for 25 days: A case report
  104. Ovarian cysts during pregnancy: the role of ultrasonically guided transvaginal aspiration
  105. Follicular aspiration does not protect against the development of ovarian hyperstimulation syndrome
  106. Fluid accumulation of the uterine cavity before embryo transfer: A possible hindrance for implantation
  107. Intrauterine Insemination with Washed Capacitated Sperm Cells in the Treatment of Male Factor, Cervical Factor and Unexplained Infertility
  108. ROCKWELL AIM 65/AIM 680 APPLICATIONS IN DISTRIBUTED PROCESS CONTROL
  109. About the editors
  110. Polycystic ovarian syndrome
  111. Foreword by Alan H. De Cherney
  112. Gonadotropins in ovarian stimulation
  113. Ovulation induction for hypogonadotropic hypogonadism
  114. Ovarian hyperstimulation for poor responders
  115. Natural cycle IVF
  116. Ovulation induction for anovulatory patients
  117. Mild ovarian hyperstimulation in combination with intrauterine insemination
  118. In vitro maturation of oocytes
  119. Triggering of final oocyte maturation in ovarian stimulation
  120. Evidence-Based Medicine Comparing hMG/FSH and Agonist/Antagonist and rec/Urinary hCG/LH/GnRH to Trigger Ovulation
  121. Congenital uterine malformations
  122. Ultrasonography of the cervix